Distrusted disclosures: Deception drives anti-transgender but not anti-atheist prejudice

IntroductionTransgender individuals face high levels of prejudice in interpersonal relationships. However, limited experimental research has examined the role of identity disclosure on anti-transgender prejudice.MethodsDrawing upon research on distrust and identity disclosure, two between-participants experiments (total n = 802) examined the role of intentional and unintentional identity disclosure on negative attitudes (Studies 1 & 2), perceived deception (Studies 1 & 2) and distrust (Study 2) toward two potentially concealable and historically distrusted identities (transgender and atheist). Specifically, the current studies examine the impact of a target’s stigmatized identity (transgender or atheist) and method of disclosure (intentional or unintentional) on perceptions of the target, perceived deceptiveness, and distrust toward the target.ResultsOur findings demonstrated that compared to atheists, transgender targets elicited greater levels of prejudice and were viewed as more deceptive, and that this effect was amplified if the target did not intentionally reveal their identity. Study 2 demonstrated that perceived deception mediated the relationship between reveal type (i.e., intentional vs. unintentional) and prejudice toward participants who read about a transgender (but not atheist) target.DiscussionWe discuss the implications of these findings for reducing prejudice toward binary transgender individuals, particularly those who do not voluntarily disclose their identity

Scoping review of indicators and methods of measurement used to evaluate the impact of dog population management interventions

Background: Dogs are ubiquitous in human society and attempts to manage their populations are common to most countries. Managing dog populations is achieved through a range of interventions to suit the dog population dynamics and dog ownership characteristics of the location, with a number of potential impacts or goals in mind. Impact assessment provides the opportunity for interventions to identify areas of inefficiencies for improvement and build evidence of positive change. Methods: This scoping review collates 26 studies that have assessed the impacts of dog population management interventions. Results: It reports the use of 29 indicators of change under 8 categories of impact and describes variation in the methods used to measure these indicators. Conclusion: The relatively few published examples of impact assessment in dog population management suggest this field is in its infancy; however this review highlights those notable exceptions. By describing those indicators and methods of measurement that have been reported thus far, and apparent barriers to efficient assessment, this review aims to support and direct future impact assessment

Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis

Background: studies in separate cohorts suggest possible discrepancies between inhaled medicines supplied (median 50-60%) and medicines used (median 30-40%). We performed the first study that directly compares CF medicine supply against use to identify the cost of excess medicines supply.Methods: this cross-sectional study included participants from 12 UK adult centres with ≥1 year of continuous adherence data from data-logging nebulisers. Medicine supply was measured as medication possession ratio (MPR) for a 1-year period from the first suitable supply date. Medicine use was measured as electronic data capture (EDC) adherence over the same period. The cost of excess medicines was calculated as whole excess box(es) supplied after accounting for the discrepancy between EDC adherence and MPR with 20% contingency.Results: among 275 participants, 133 (48.4%) were females and mean age was 30 years (95% CI 29-31 years). Median EDC adherence was 57% (IQR 23-86%), median MPR was 74% (IQR 46-96%) and the discrepancy between measures was median 14% (IQR 2-29%). Even with 20% contingency, mean potential cost of excess medicines was £1,124 (95% CI £855-1,394), ranging from £183 (95% CI £29-338) for EDC adherence ≥80% to £2,017 (95% CI £1,507-2,526) for EDC adherence &lt;50%.Conclusions: this study provides a conservative estimate of excess inhaled medicines supply cost among adults with CF in the UK. The excess supply cost was highest among those with lowest EDC adherence, highlighting the importance of adherence support and supplying medicine according to actual use. MPR provides information about medicine supply but over-estimates actual medicine use.</p

ManyLabs Africa

A multisite preregistered replication of 3 African effects in North American, European, and African populations

Ethics

We provide information about the ethics application and certificates obtained for the MLA stud